Discover · The Research Behind It

Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis — Henssler et al., Lancet Psychiatry 2024

Last checked

  • Free
  • Worldwide
  • Research paper
  • Reading
  • Online

Never stop or reduce a prescribed medicine on your own: some medicines cause withdrawal effects or a relapse if they are stopped or cut down too quickly. Use these resources to plan it with your prescriber.

Published in
The Lancet Psychiatry, 2024
Evidence
Moderate
Cost
Free.

What is this paper about?

Pooled 79 studies (21,002 people) in which an antidepressant or placebo was stopped. At least one discontinuation symptom followed stopping an antidepressant in 31% (95% CI 27–35%) versus 17% after placebo; severe symptoms in 2.8% versus 0.6%. Allowing for non-specific effects seen with placebo, the authors estimate about 15% (one in six to seven). Desvenlafaxine, venlafaxine, imipramine, escitalopram and paroxetine were linked to more frequent or severe symptoms.

Why is it in the directory?

Backs up the antidepressant tapering listings in chapter 06 with a large, recent estimate of how often discontinuation symptoms occur, and helps readers weigh it against higher survey-based figures such as Davies and Read's.

Is it free to read?

Systematic review and meta-analysis — 79 studies (44 randomised trials, 35 observational), 21,002 people. Moderate evidence. Lancet Psychiatry 2024;11(7):526–535. Free full text at the publisher — open access, CC BY 4.0.

About the paper

Authors
Henssler J, Schmidt Y, Schmidt U, Schwarzer G, Bschor T, Baethge C.
Published in
Lancet Psychiatry 2024;11(7):526–535
Kind of study
Systematic review and meta-analysis — 79 studies (44 randomised trials, 35 observational), 21,002 people
Strength of evidence
Moderate — good studies, but fewer of them or with some limits
Free to read
CC BY 4.0 (open access at publisher)

Good to know

  • Heterogeneity was substantial, studies defined and measured symptoms differently and many were small; it drew critical letters, including from Read and Davies, and an erratum in 2024.

Where it sits in the directory

Listed under “Coming Off Medication Safely — Tapering & Deprescribing” in chapter 17 of the directory, The Research Behind It, with 12 other listings in the same category.

See every listing in “Coming Off Medication Safely”

Similar listings

Also in the directory, with why each one is here.

Browse all 280 in The Research Behind It

This page sums up the listing in Notbroken’s own words, from the provider’s own pages; Notbroken does not run it. A listing is not a recommendation, and Notbroken hasn’t tested the service. The details were last checked against the paper and its listing on 25 October 2026; the link last loaded on 7 November 2026. Page first published 7 November 2026. Services, prices and opening hours change, so check with the provider before you rely on them. General information, not medical, legal or financial advice. How these pages work · Run this service? Ask for a change.